A comparison of the effects of ivermectin and moxidectin on the nematode Caenorhabditis elegans

Veterinary Parasitology

Volumn 165, Issue 1-2, 2009, Pages 96-108

  Ardelli, Bernadette F ^a   Stitt, Laurel E ^a   Tompkins, Jeffrey B ^a   Prichard, Roger K ^b  

^a BRANDON UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Caenorhabditis elegans; Glutamate gated chloride channel; Ivermectin; Larval development; Motility; Moxidectin; Pharyngeal pump rate

Indexed keywords

ANTHELMINTIC AGENT; CHLORIDE CHANNEL; GLUTAMIC ACID; IVERMECTIN; MOXIDECTIN;

ARTICLE; BODY MOVEMENT; CAENORHABDITIS ELEGANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EXPOSURE; DRUG SENSITIVITY; GENE DELETION; GENE EXPRESSION PROFILING; GENETIC CODE; GENETIC STRAIN; GENETIC TRANSCRIPTION; LARVAL DEVELOPMENT; NEMATODE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARYNX; PHENOTYPE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; WILD TYPE;

ANIMALS; ANTIPARASITIC AGENTS; CAENORHABDITIS ELEGANS; CHLORIDE CHANNELS; GENE DELETION; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; IVERMECTIN; LARVA; MACROLIDES; MOTOR ACTIVITY; PARASITIC SENSITIVITY TESTS; PHENOTYPE; TIME FACTORS;

CAENORHABDITIS ELEGANS; NEMATODA;

EID: 70349512208     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2009.06.043     Document Type: Article

References (36)

1. Ali M.M., Mukhtar M.M., Baraka O.Z., Homeida M.M., Kheir M.M., and Mackenzie C.D. Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. Acta Trop. 84 (2002) 49-53
2. Arena J.P., Liu K.K., Paress P.S., Frazier E.G., Cully D.F., Mrozik H., and Schaeffer J.M. The mechanism of action of avermectins in Caenorhabditis elegans: correlation between activation of glutamate-sensitive chloride current, membrane binding, and biological activity. J. Parasitol. 81 (1995) 286-294
3. Avery L., and Horvitz H.R. Effects of starvation and neuroactive drugs on feeding in Caenorhabditis elegans. J. Exp. Zool. 253 (1990) 263-270
4. Awadzi K., Boakye D.A., Edwards G., Opoku N.O., Attah S.K., Osei-Atweneboana M.Y., Lazdins-Helds J.K., Ardrey A.E., Addy E.T., Quartey B.T., Ahmed K., Boatin B.A., and Soumbey-Alley E.W. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 98 (2004) 231-249
5. Awadzi K., Attah S.K., Addy E.T., Opoku N.O., Quartey B.T., Lazdins-Helds J.K., Ahmed K., Boatin B.A., Boakye D.A., and Edwards G. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 98 (2004) 359-370
6. Brenner S. The genetics of Caenorhabditis elegans. Genetics 77 (1974) 71-94
7. Campbell W.C. Ivermectin, an antiparasitic agent. Med. Res. Rev. 13 (1993) 61-79
8. Chalasani S.H., Chronis N., Tsunozaki M., Gray J.M., Ramot D., Goodman M.B., and Bargmann C.I. Dissecting a circuit for olfactory behaviour in Caenorhabditis elegans. Nature 450 (2007) 63-70
9. Contreau M.M., Warren S., Ryan J.L., Fleckenstein L., Vanapalli S.R., Brown K.R., Rock D., Chen C.Y., and Schwertschlag U.S. The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans. J. Clin. Pharmacol. 43 (2003) 1108-1115
10. Cook A., Aptel N., Portillo V., Siney E., Sihota R., Holden-Dye L., and Wolstenholme A. Caenorhabditis elegans ivermectin receptors regulate locomotor behaviour and are functional orthologues of Haemonchus contortus receptors. Mol. Biol. Parasitol. 147 (2006) 118-125
11. Craig T.M., Hatfield T.A., Pankavich J.A., and Wang G.T. Efficacy of moxidectin against an ivermectin-resistant strain of Haemonchus contortus in sheep. Vet. Parasitol. 41 (1992) 329-333
12. Cully D.F., Vassilatis D.K., Liu K.K., Paress P.S., Van der Ploeg L.H., Schaeffer J.M., and Arena J.P. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371 (1994) 707-711
13. de Bono M., and Maricq A.V. Neuronal substrates of complex behaviors in C. elegans. Annu. Rev. Neurosci. 28 (2005) 451-501
14. Dent J.A., Mchardy M.S., Vassilatis D.M., and Avery L. The genetics of ivermectin resistance in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 2674-2979
15. Dent J.A., Davis M.W., and Avery L. Avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J. 16 (1997) 5867-5879
16. Geary T.G., Sims S.M., Thomas E.M., Vanover L., Davis J.P., Winterrowd C.A., Klein R.D., Ho N.F., and Thompson D.P. Haemonchus contortus: ivermectin-induced paralysis of the pharynx. Exp. Parasitol. 77 (1993) 88-96
17. Gray J.M., Hill J.J., and Bargmann C.I. A circuit for navigation in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 3184-3191
18. Horoszok L., Raymond V., Sattelle D.B., and Wolstenholme A.J. GLC-3: a novel fipronil and BIDN-sensitive, but picrotoxinin-insensitive, l-glutamate-gated chloride channel subunit from Caenorhabditis elegans. Br. J. Pharmacol. 132 (2001) 1247-1254
19. 1a binds to high- and low-affinity sites with dual effects on the γ-aminobutyric acid-gated chloride channel of cultured cerebellar granule neurons. J. Pharm. Exp. Ther. 281 (1997) 261-266
20. Kass I.S., Wang C.C., Walrond J.P., and Stretton A.O. Avermectin B1a, a paralyzing anthelmintic that affects interneurons and inhibitory motoneurons in Ascaris. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 6211-6215
21. Keane J., and Avery L. Mechanosensory inputs influence Caenorhabditis elegans pharyngeal activity via ivermectin sensitivity genes. Genetics 164 1 (2003) 153-162
22. Kedzierski W., and Porter J.C. A novel non-enzymatic procedure for removing DNA template from RNA transcription mixtures. Biotechniques 10 (1991) 210-214
23. Laughton D.L., Lunt G.G., and Wolstenholme A.J. Reporter gene constructs suggest that the Caenorhabditis elegans avermectin receptor beta-subunit is expressed solely in the pharynx. J. Exp. Biol. 200 (1997) 1509-1514
24. Lespine A., Martin S., Dupuy J., Roulet A., Pineau T., Orlowski S., and Alvinerie M. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur J Pharm Sci. 30 1 (2007) 84-94
25. Molento M.B., Lifschitz A., Sallovitz J., Lanusse C., and Prichard R. Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep. Parasitol. Res. 92 (2004) 121-127
26. Omura S., and Crump A. The life and times of ivermectin-a success story. Nat. Rev. Microbiol. 2 (2004) 984-989
27. Oosthuizen W.T., and Erasmus J.B. Efficacy of moxidectin against a strain of Haemonchus contortus resistant to ivermectin, a benzimidazole and a salicylanilide. J. S. Afr. Vet. Assoc. 64 (1993) 9-12
28. Osei-Atweneboana M.Y., Eng J.K.L., Boakye D.A., Gyapong J.O., and Prichard R.K. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two phase epidemiological study. Lancet 369 (2007) 2021-2029
29. Pankavich J.A., Berger H., and Simkins K.L. Efficacy of moxidectin, nemadectin and ivermectin against an ivermectin-resistant strain of Haemonchus contortus in sheep. Vet. Rec. 130 (1992) 241-242 243
30. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res. 29 (2001) e45
31. Pomroy W.E., Whelan N., Alexander A.M., West D.W., Stafford K., Adlington B.A., and Calder S.M. Multiple resistance in goat-derived Ostertagia and the efficacy of moxidectin and combinations of other anthelmintics. N.Z. Vet. J. 40 (1992) 76-78
32. Shoop, W., 2003. Cross-resistance among the avermectins In: Dadzie Y., Neira M., Hopkins D. Final report of the Conference on the eradicability of Onchocerciasis. Filaria J, 2:2.
33. Shoop W., and Soll M. Chemistry, pharmacology and safety of the macrocyclic lactones. In: Vercruysse J., and Rew R.S. (Eds). Macrocyclic Lactones in Antiparasitic Therapy (2002), CAB International 1-29
34. Shoop W.L., Mrozik H., and Fisher M.H. Structure and activity of avermectins and milbemycins in animal health. Vet. Parasitol. 59 (1995) 139-156
35. Vassilatis D.K., Arena J.P., Plasterk R.H., Wilkinson H.A., Schaeffer J.M., Cully D.F., and Van der Ploeg L.H. Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization. J. Biol. Chem. 272 (1997) 33167-33174
36. Yates D.M., Portillo V., and Wolstenholme A.J. The avermectin receptors of Haemonchus contortus and Caenorhabditis elegans. Int. J. Parasitol. 33 (2003) 1183-1193